Last update :
14/06/2024
Sympathomimetic   Norepinephrine bitartrate  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Adine Chile
Arterenol Germany
Biemefrin Turkey
Boguefren Mexico
Cardenor Turkey
Cardiamed Malaysia
Drenorep Peru
Epinor India
Fioritina Argentina
Hyponor Brazil
Levonor Poland
Levophed Belgium, Canada, Chile, Luxembourg, Malaysia, New Zealand, Saudi Arabia, United Arab Emirates, United States of America
Levophrine Egypt
Nadrin India
Naretia Mexico
Nepridar Mexico
Noradren Peru
Noradrenalin Norway
Noradrenaline France, Great Britain, Ireland, Romania, Switzerland, Tunisia
Norages Spain
Norepine Belgium
Pridam Chile, Mexico
Radrenit Mexico
Softamicid Mexico
Steradine Turkey
Tehipren Mexico
Stability of mixtures   Injection   Stability of mixtures : Norepinephrine bitartrate     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass Glucose 5% 0,06 mg/ml
Injection   Norepinephrine bitartrate   
Injection   Dopamine hydrochloride 5 mg/ml
22°C
24 Hour
3381
Glass Glucose 5% 0,06 mg/ml
Injection   Norepinephrine bitartrate   
Injection   Dobutamine hydrochloride 5 mg/ml
22°C
24 Hour
3381
Glass Glucose 5% 0,06 mg/ml
Injection   Norepinephrine bitartrate   
Injection   Dobutamine hydrochloride 5 mg/ml
Injection   Amiodarone hydrochloride 12,5 mg/ml
22°C
24 Hour
3381
Glass Glucose 5% 0,03 mg/ml
Injection   Norepinephrine bitartrate   
Injection   Milrinone lactate 0,2 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,032 mg/ml
Injection   Norepinephrine bitartrate   
Injection   Levofloxacine 2,5 mg/ml
25°C
4 Hour
3865
Level of evidence A+
Glass Glucose 5% 0,032 mg/ml
Injection   Norepinephrine bitartrate   
Injection   Moxifloxacin 0,8 mg/ml
25°C
4 Hour
3865
Level of evidence A+
Polyvinyl chloride Glucose 5% 0,004 mg/ml
Injection   Norepinephrine bitartrate   
Injection   Ranitidine hydrochloride 2 mg/ml
?
4 Hour
Not specified 210
Level of evidence B
Polyvinyl chloride Glucose 5% 0,008 mg/ml
Injection   Norepinephrine bitartrate   
Injection   Ranitidine hydrochloride 2 mg/ml
?
12 Hour
Not specified 210
Level of evidence B
Polyvinyl chloride Glucose 5% 0,004 & 0,008 mg/ml
Injection   Norepinephrine bitartrate   
Injection   Ranitidine hydrochloride 0,05 mg/ml
?
48 Hour
Not specified 210
Level of evidence B
Polyethylene Glucose 5% 0,06 mg/ml
Injection   Norepinephrine bitartrate   
Injection   Dopamine hydrochloride 5 mg/ml
22°C
24 Hour
3381
Polyethylene Glucose 5% 0,06 mg/ml
Injection   Norepinephrine bitartrate   
Injection   Dobutamine hydrochloride 5 mg/ml
22°C
24 Hour
3381
Polyethylene Glucose 5% 0,06 mg/ml
Injection   Norepinephrine bitartrate   
Injection   Dobutamine hydrochloride 5 mg/ml
Injection   Amiodarone hydrochloride 12,5 mg/ml
22°C
24 Hour
3381
Polypropylene Sodium chloride 0,9% 0,032 mg/ml
Injection   Norepinephrine bitartrate   
Injection   Piperacillin sodium / tazobactam 20 / 2.5 mg/ml
22-23°C
24 Hour
Protect from light 4758
Level of evidence B
Polypropylene NaCl 0,45% Glucose 2,5% 0,032 mg/ml
Injection   Norepinephrine bitartrate   
Injection   Moxifloxacin 8 mg/ml
22-23°C
24 Hour
Protect from light 4758
Level of evidence B

  Mentions Légales